Lung Cancer Surgery Market Size, Share, Growth & Industry Analysis, By Surgical Procedure (Thoracotomy and Minimally Invasive Surgeries), By Surgical Devices (Surgical Instruments, Monitoring Devices & Systems, and Endosurgical Equipment), and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL LUNG CANCER SURGERY MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL LUNG CANCER SURGERY MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
6.1 Overview
6.2 Thoracotomy
6.3 Minimally Invasive Surgeries

7 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL DEVICES
7.1 Overview
7.2 Surgical Instruments
7.3 Monitoring Devices & Systems
7.4 Endosurgical Equipment

8 GLOBAL LUNG CANCER SURGERY MARKET, BY GEOGRAPHY
8.1 Overview

9 NORTH AMERICA 
9.1 U.S.
9.2 Canada
9.3 Mexico

10 EUROPE 
10.1 Germany
10.2 U.K.
10.3 France
10.4 Italy
10.5 Spain
10.6 Russia
10.7 Rest of Europe

11 ASIA-PACIFIC 
11.1 China
11.2 Japan
11.3 India
11.4 South Korea
11.5 Rest of Asia-Pacific

12 MIDDLE EAST & AFRICA 
12.1 GCC
12.2 South Africa
12.3 North Africa
12.4 Rest of Middle East & Africa

13 LATIN AMERICA 
13.1 Brazil
13.2 Argentina
13.3 Rest of South America

14  GLOBAL LUNG CANCER SURGERY MARKET COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Key Developments
14.3 Key Strategic Developments
14.4 Company Market Ranking
14.5 Regional Footprint
14.6 Industry Footprint

15 COMPANY PROFILES
15.1 Accuray Incorporated
15.1.1 Key Facts
15.1.2 Financial Overview
15.1.3 Product Benchmarking
15.1.4 Recent Developments
15.1.5 Winning Imperatives
15.1.6 Current Focus & Strategies
15.1.7 Threat from competition
15.1.8 SWOT Analysis
15.2 AngioDynamics
15.2.1 Key Facts
15.2.2 Financial Overview
15.2.3 Product Benchmarking
15.2.4 Recent Developments
15.2.5 Winning Imperatives
15.2.6 Current Focus & Strategies
15.2.7 Threat from competition
15.2.8 SWOT Analysis
15.3 Intuitive Surgical
15.3.1 Key Facts
15.3.2 Financial Overview
15.3.3 Product Benchmarking
15.3.4 Recent Developments
15.3.5 Winning Imperatives
15.3.6 Current Focus & Strategies
15.3.7 Threat from competition
15.3.8 SWOT Analysis
15.4 Olympus America
15.4.1 Key Facts
15.4.2 Financial Overview
15.4.3 Product Benchmarking
15.4.4 Recent Developments
15.4.5 Winning Imperatives
15.4.6 Current Focus & Strategies
15.4.7 Threat from competition
15.4.8 SWOT Analysis
15.5 Teleflex Incorporated
15.5.1 Key Facts
15.5.2 Financial Overview
15.5.3 Product Benchmarking
15.5.4 Recent Developments
15.5.5 Winning Imperatives
15.5.6 Current Focus & Strategies
15.5.7 Threat from competition
15.5.8 SWOT Analysis
15.6 Karl Storz SE & Co
15.6.1 Key Facts
15.6.2 Financial Overview
15.6.3 Product Benchmarking
15.6.4 Recent Developments
15.6.5 Winning Imperatives
15.6.6 Current Focus & Strategies
15.6.7 Threat from competition
15.6.8 SWOT Analysis
15.7 Siemens Healthcare Private Limited 
15.7.1 Key Facts
15.7.2 Financial Overview
15.7.3 Product Benchmarking
15.7.4 Recent Developments
15.7.5 Winning Imperatives
15.7.6 Current Focus & Strategies
15.7.7 Threat from competition
15.7.8 SWOT Analysis
15.8 Medtronic
15.8.1 Key Facts
15.8.2 Financial Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments
15.8.5 Winning Imperatives
15.8.6 Current Focus & Strategies
15.8.7 Threat from competition
15.8.8 SWOT Analysis
15.9 Wexler Surgical
15.9.1 Key Facts
15.9.2 Financial Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments
15.9.5 Winning Imperatives
15.9.6 Current Focus & Strategies
15.9.7 Threat from competition
15.9.8 SWOT Analysis
15.10 Richard Wolf GmbH 
15.10.1 Key Facts
15.10.2 Financial Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments
15.10.5 Winning Imperatives
15.10.6 Current Focus & Strategies
15.10.7 Threat from competition
15.10.8 SWOT Analysis

LIST OF TABLES 

TABLE 1 Global Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 2 Global Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 3 Global Lung Cancer Surgery Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 4 North America Lung Cancer Surgery Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 5 North America Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 6 North America Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 7 US Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 8 US Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 9 Canada Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 10 Canada Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 11 Mexico Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 12 Mexico Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 13 Europe Lung Cancer Surgery Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 14 Europe Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 15 Europe Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 16 Germany Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 17 Germany Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 18 France Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 19 France Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 20 U.K. Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 21 U.K. Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 22 Spain Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 23 Spain Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 24 Italy Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 25 Italy Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 26 Russia Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 27 Russia Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 28 Rest of Europe Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 29 Rest of Europe Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 30 Asia-Pacific Lung Cancer Surgery Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 31 Asia-Pacific Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 32 Asia-Pacific Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 33 China Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 34 China Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 35 Japan Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 36 Japan Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 37 India Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 38 India Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 39 South Korea Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 40 South Korea Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 41 Rest of Asia-Pacific Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 42 Rest of Asia-Pacific Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 43 Middle East and Africa Lung Cancer Surgery Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 44 Middle East and Africa Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 45 Middle East and Africa Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 46 GCC Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 47 GCC Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 48 North Africa Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 49 North Africa Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 50 South Africa Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 51 South Africa Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 52 Rest of Middle East & Africa Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 53 Rest of Middle East & Africa Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 54 Latin America Lung Cancer Surgery Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 55 Latin America Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 56 Latin America Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 57 Brazil Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 58 Brazil Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 59 Argentina Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 60 Argentina Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 61 Rest of Latin America Lung Cancer Surgery Market Revenue, By Surgical Procedure, 2021 – 2031 (USD Million)
TABLE 62 Rest of Latin America Lung Cancer Surgery Market Revenue, By Surgical Devices, 2021 – 2031 (USD Million)
TABLE 63 Company Market Ranking
TABLE 64 Regional Footprint
TABLE 65 Product Benchmarking
TABLE 66 Recent Developments
TABLE 67 Winning Imperatives

LIST OF FIGURES 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Lung Cancer Surgery Market 2021-2031 (USD Million)
FIG. 4 Global Lung Cancer Surgery Market Geographical Analysis (CAGR %)
FIG. 5 Global Lung Cancer Surgery Absolute Market Opportunity (USD Million)
FIG. 6 Global Lung Cancer Surgery Market Attractiveness (USD Million)
FIG. 7 Global Lung Cancer Surgery Market, By Surgical Procedure, 2021-2031 (USD Million)
FIG. 8 Global Lung Cancer Surgery Market, By Surgical Devices, 2021-2031 (USD Million)
FIG. 9 Research Methodology
FIG. 10 Research Process
FIG. 11 Bottom-Up Approach
FIG. 12 Top-Bottom Approach
FIG. 13 Market Dynamics Overview
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Value Chain Analysis
FIG. 16 Macroeconomic Analysis
FIG. 17 Global Lung Cancer Surgery Market Revenue Share, By Surgical Procedure, 2023 and 2031 (%)
FIG. 18 Global Lung Cancer Surgery Market Revenue Share, By Surgical Devices, 2023 and 2031 (%)
FIG. 19 Global Lung Cancer Surgery Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 20 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 21 North America Lung Cancer Surgery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 Europe Lung Cancer Surgery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Asia-Pacific Lung Cancer Surgery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Middle East & Africa Lung Cancer Surgery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Latin America Lung Cancer Surgery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Key Strategic Development
FIG. 31 Key Facts
FIG. 32 Financial Overview
FIG. 33 SWOT Analysis